Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Other Non Operating Income: 2011-2021

Historic Other Non Operating Income for Enanta Pharmaceuticals (ENTA) over the last 10 years, with Sep 2021 value amounting to -$27,000.

  • Enanta Pharmaceuticals' Other Non Operating Income fell 10.48% to $393,000 in Q2 2022 from the same period last year, while for Jun 2022 it was -$782,000, marking a year-over-year increase of 78.64%. This contributed to the annual value of -$27,000 for FY2021, which is 118.12% down from last year.
  • According to the latest figures from FY2021, Enanta Pharmaceuticals' Other Non Operating Income is -$27,000, which was down 118.12% from $149,000 recorded in FY2020.
  • In the past 5 years, Enanta Pharmaceuticals' Other Non Operating Income ranged from a high of $149,000 in FY2020 and a low of -$159,000 during FY2017.
  • Its 2-year average for Other Non Operating Income is $61,000, with a median of $61,000 in 2020.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Other Non Operating Income tumbled by 648.28% in 2017, and later surged by 62.89% in 2018.
  • Enanta Pharmaceuticals' Other Non Operating Income (Yearly) stood at -$159,000 in 2017, then soared by 62.89% to -$59,000 in 2018, then reached $149,000 in 2020, then crashed by 118.12% to -$27,000 in 2021.